Welcome to our dedicated page for VEECO INSTRUMENTS SEC filings (Ticker: VECO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VEECO INSTRUMENTS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VEECO INSTRUMENTS's regulatory disclosures and financial reporting.
Veeco Instruments senior vice president of global sales and service Susan Wilkerson acquired 32,000 shares of common stock on a restricted basis under the Veeco Instruments Inc. 2019 Stock Incentive Plan. These shares are subject to vesting, with one-third of the award scheduled to lapse on each of the first, second and third anniversaries of the grant date, contingent on her continued service. Following this equity award, she directly holds a total of 84,154.525 Veeco common shares.
VEECO INSTRUMENTS INC reported that CEO and director William John Miller sold a total of 50,000 shares of common stock in open-market transactions on March 3, 2026. The sales occurred in two 25,000‑share blocks at weighted average prices of $31.24 and $32.00 per share.
After these transactions, Miller directly held 414,543 shares of Veeco common stock. Footnotes state that the reported prices are weighted averages, with actual sale prices ranging from $30.95 to $31.51 per share for the first trade and from $32.00 to $32.02 per share for the second.
Veeco Instruments Inc. files its annual report describing a global semiconductor equipment business focused on laser annealing, ion beam, MOCVD, CVD, lithography, wet processing, MBE and ALD tools serving four end-markets: Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other.
Veeco highlights a pending merger with Axcelis Technologies under which Veeco would become a wholly owned subsidiary after regulatory approvals, with stockholders of both companies already approving the deal. Backlog grew to $554.9 million as of December 31, 2025, up from $409.6 million a year earlier, reflecting strong order visibility in cyclical markets.
The report details extensive risk factors, including heavy exposure to non‑U.S. sales, tightening U.S.–China export controls, tariffs, supply-chain dependence on limited suppliers, rapid technology change, cybersecurity threats, and constraints and fees associated with the Axcelis merger. Veeco also notes $230.0 million of 2029 convertible notes and a $250.0 million undrawn credit facility, as well as a workforce of 1,265 employees with relatively low voluntary turnover.
Veeco Instruments reported lower results for the fourth quarter and full year 2025 but issued an outlook calling for growth in 2026. Q4 2025 revenue was $165.0 million versus $182.1 million a year earlier, with GAAP diluted EPS of $0.02 compared with $0.26. Full-year 2025 revenue was $664.3 million versus $717.3 million in 2024, and GAAP diluted EPS declined to $0.59 from $1.23; non-GAAP diluted EPS fell to $1.33 from $1.74. Management cited accelerated bookings in semiconductor, compound semiconductor and data storage markets and referenced a planned merger with Axcelis as positioning the business for AI and high-performance computing demand. For Q1 2026, Veeco guides net sales of $150–$170 million and non-GAAP diluted EPS of $0.14–$0.24, and for full-year 2026 it guides net sales of $740–$800 million with non-GAAP diluted EPS of $1.50–$1.85.
Manulife Financial Corporation and its investment subsidiaries filed an amended Schedule 13G reporting their institutional ownership of Veeco Instruments Inc. common stock as of December 31, 2025.
Manulife Investment Management (US) LLC beneficially owned 2,531,978 shares, or 4.21% of Veeco’s common stock, while Manulife Investment Management Ltd held 18,615 shares, or 0.03%. Veeco had 60,162,510 shares outstanding as of October 30, 2025. Manulife Financial Corporation itself reported no directly held shares but may be deemed to beneficially own the shares held by its subsidiaries. The filing indicates the Manulife group’s aggregate holdings are 5 percent or less of Veeco’s common stock.
Axcelis Technologies provides an update on its pending merger with Veeco, describing the deal as a transformational step to create a new leader in semiconductor capital equipment with complementary technologies and a broader market opportunity.
Integration teams across all functional and operational areas have been formed and have already held a second integration summit with more than 50 employees from both companies. Regulatory clearances have been obtained for the U.S. Hart-Scott-Rodino filing and foreign direct investment approvals in Ireland, Germany and the UK, with approval from China’s State Administration for Market Regulation still pending. Both Axcelis and Veeco stockholders approved the merger at meetings held on February 6, 2026. The message also reminds investors that a Form S-4 registration statement and a joint proxy statement/prospectus are on file with the SEC and emphasizes the risks and uncertainties typical of large mergers, including regulatory approvals, integration challenges, costs and potential impacts on relationships with customers, suppliers and employees.
Veeco Instruments Inc. reported that its stockholders approved all proposals related to the company’s pending merger with Axcelis Technologies, Inc. at a special meeting held on February 6, 2026. The merger agreement proposal received 53,408,907 votes for, 469,828 against and 10,875 abstentions, satisfying the required majority of outstanding shares.
As of the December 26, 2025 record date, 60,297,087 shares were outstanding, with 53,889,610 shares, or about 89.37% of voting power, present to constitute a quorum. Completion of the merger still requires remaining customary closing conditions, including final regulatory approval from China’s State Administration for Market Regulation, and is expected in the second half of 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G reporting their beneficial ownership of 6,077,505.67 shares of Veeco Instruments Inc. common stock, representing 10.1% of the class.
FMR LLC has sole voting power over 6,038,927.95 shares and sole dispositive power over 6,077,505.67 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over the same 6,077,505.67 shares. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Veeco.
Veeco Instruments Inc. received an amended Schedule 13G showing that FMR LLC and Abigail P. Johnson collectively report beneficial ownership of 5,926,996.32 shares of Veeco common stock, representing 9.8% of the class as of 12/31/2025.
FMR LLC reports sole voting power over 5,862,796.95 shares and sole dispositive power over 5,926,996.32 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over the same 5,926,996.32 shares and no voting power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Veeco. One or more other persons may have rights to dividends or sale proceeds, but no such person holds more than five percent of the common stock.